TABLE 1

Potencies of various histamine derivatives at NMDAR-mediated responses

For agonists, data are EC50 (micromolar) values, relative potency, and intrinsic activity (in parentheses, respectively). For antagonists/inverse agonists, data are IC50 (micromolar) values. The EC50 values on [3H]noradrenaline release were obtained from the concentration-response curves shown in Figs. 3 and 4. The relative potencies were determined by comparison with that of histamine (=100). The intrinsic activities were determined by comparison with the maximal effect of histamine.

Potentiation of [3H]Noradrenaline ReleasePotentiation of NMDA CurrentsProperty at Brain Histaminergic Receptors
Agonist
    Histamine99 ± 17 (100) (1)1.7 −10a,b,c (100) (1)Agonist
    HistidineNo effect at 100No effect at 100cNot active
    4-Methylimidazole93 ± 10 (106) (1)Not testedNot active
    pros-MethylhistamineNo effect at 100No effect at 10cNot active
    tele-Methylhistamine97 ± 22 (102) (1)7.2 ± 1.5 (122) (1)Not active
    Nα-MethylhistamineNo effect at 100No effect at 10cAgonist
    Nα,Nα-DimethylhistamineNo effect at 100Not testedAgonist
    (R)-α-Methylhistamine41 ± 24 (241) (0.3)EC50 ≈ 10c (100)H3-Agonist
    Burimamide6 ± 2 (1650) (0.4)Not testedH2/H3-Antagonist
    2-Pyridylethylamine5 ± 0.5 (1980) (1)Not testedH1-Agonist
Antagonist/inverse agonist
    Impromidine15 ± 3≈10bH2-Agonist/H3-antagonist
    ImetitInhibitory effect at 100Inhibitory effect at 10cH3-Agonist
    ThioperamideNo effect at 2No effect at 10bH3-Antagonist
  • a Data from Vorobjev et al. (1993).

  • b Data from Bekkers (1993).

  • c Data from Williams (1994a).